v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Parent
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interest
Beginning balance (in shares) at Jan. 31, 2025     334,301          
Beginning balance at Jan. 31, 2025 $ 3,006,643 $ 2,999,929 $ 34 $ (59,505) $ 10,355,211 $ (2,236) $ (7,293,575) $ 6,714
Beginning balance, treasury stock (in shares) at Jan. 31, 2025       (436)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)     4,412          
Issuance of common stock upon exercise of stock options 36,678 36,678     36,678      
Issuance of common stock under employee stock purchase plan (in shares)     554          
Issuance of common stock under employee stock purchase plan 53,193 53,193     53,193      
Vesting of restricted stock units (in shares)     4,753          
Shares withheld related to net share settlement of equity awards (in shares)     (1,627)          
Issuance of common stock in connection with a business combination subject to future vesting (297,470) (297,470)     (297,470)      
Repurchases and retirement of common stock, including transaction costs and excise tax, if any (in shares)     (3,214)          
Repurchases and retirement of common stock, including transaction costs and excise tax, if any (490,638) (490,638)         (490,638)  
Reissuance of treasury stock upon settlement of equity awards (in shares)       19        
Reissuance of treasury stock upon settlement of equity awards 0     $ 2,537 (2,537)      
Stock-based compensation 794,047 794,047     794,047      
Other comprehensive income (loss) 5,018 5,018       5,018    
Net income (loss) (727,882) (728,109)         (728,109) 227
Ending balance (in shares) at Jul. 31, 2025     339,179          
Ending balance at Jul. 31, 2025 2,379,589 2,372,648 $ 34 $ (56,968) 10,939,122 2,782 (8,512,322) 6,941
Ending balance, treasury stock (in shares) at Jul. 31, 2025       (417)        
Beginning balance (in shares) at Apr. 30, 2025     334,064          
Beginning balance at Apr. 30, 2025 2,414,854 2,408,000 $ 34 $ (58,153) 10,672,455 8,171 (8,214,507) 6,854
Beginning balance, treasury stock (in shares) at Apr. 30, 2025       (426)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)     3,565          
Issuance of common stock upon exercise of stock options 30,460 30,460     30,460      
Vesting of restricted stock units (in shares)     2,338          
Shares withheld related to net share settlement of equity awards (in shares)     (788)          
Issuance of common stock in connection with a business combination subject to future vesting (166,136) (166,136)     (166,136)      
Repurchases and retirement of common stock, including transaction costs and excise tax, if any 202 202         202  
Reissuance of treasury stock upon settlement of equity awards (in shares)       9        
Reissuance of treasury stock upon settlement of equity awards 0     $ 1,185 (1,185)      
Stock-based compensation 403,528 403,528     403,528      
Other comprehensive income (loss) (5,389) (5,389)       (5,389)    
Net income (loss) (297,930) (298,017)         (298,017) 87
Ending balance (in shares) at Jul. 31, 2025     339,179          
Ending balance at Jul. 31, 2025 $ 2,379,589 $ 2,372,648 $ 34 $ (56,968) 10,939,122 2,782 (8,512,322) $ 6,941
Ending balance, treasury stock (in shares) at Jul. 31, 2025       (417)        
Beginning balance (in shares) at Jan. 31, 2026 343,918   344,317          
Beginning balance at Jan. 31, 2026 $ 1,924,102   $ 34 $ (54,488) 11,469,468 3,337 (9,494,249)  
Beginning balance, treasury stock (in shares) at Jan. 31, 2026 (399)     (399)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares) 4,453   4,453          
Issuance of common stock upon exercise of stock options $ 74,378   $ 1   74,377      
Issuance of common stock under employee stock purchase plan (in shares)     445          
Issuance of common stock under employee stock purchase plan 66,987       66,987      
Issuance of common stock in connection with business combinations (in shares)     1,954          
Issuance of common stock in connection with business combinations 395,870       395,870      
Issuance of common stock in connection with a business combination subject to future vesting (in shares)     268          
Vesting of restricted stock units (in shares)     4,676          
Shares withheld related to net share settlement of equity awards (in shares)     (1,601)          
Issuance of common stock in connection with a business combination subject to future vesting (329,880)       (329,880)      
Repurchases and retirement of common stock, including transaction costs and excise tax, if any (in shares)     (1,676)          
Repurchases and retirement of common stock, including transaction costs and excise tax, if any (300,003)           (300,003)  
Reissuance of treasury stock upon settlement of equity awards (in shares)       18        
Reissuance of treasury stock upon settlement of equity awards 0     $ 2,498 (2,498)      
Stock-based compensation 826,815       826,815      
Other comprehensive income (loss) (21,314)         (21,314)    
Net income (loss) $ (487,291)           (487,291)  
Ending balance (in shares) at Jul. 31, 2026 352,455   352,836          
Ending balance at Jul. 31, 2026 $ 2,149,664   $ 35 $ (51,990) 12,501,139 (17,977) (10,281,543)  
Ending balance, treasury stock (in shares) at Jul. 31, 2026 (381)     (381)        
Beginning balance (in shares) at Apr. 30, 2026     346,991          
Beginning balance at Apr. 30, 2026 $ 1,939,722   $ 34 $ (53,261) 12,086,411 (3,639) (10,089,823)  
Beginning balance, treasury stock (in shares) at Apr. 30, 2026       (390)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in shares)     3,621          
Issuance of common stock upon exercise of stock options 67,864   $ 1   67,863      
Issuance of common stock in connection with business combinations (in shares)     458          
Issuance of common stock in connection with business combinations 110,522       110,522      
Issuance of common stock in connection with a business combination subject to future vesting (in shares)     225          
Vesting of restricted stock units (in shares)     2,337          
Shares withheld related to net share settlement of equity awards (in shares)     (796)          
Issuance of common stock in connection with a business combination subject to future vesting (186,520)       (186,520)      
Reissuance of treasury stock upon settlement of equity awards (in shares)       9        
Reissuance of treasury stock upon settlement of equity awards 0     $ 1,271 (1,271)      
Stock-based compensation 424,134       424,134      
Other comprehensive income (loss) (14,338)         (14,338)    
Net income (loss) $ (191,720)           (191,720)  
Ending balance (in shares) at Jul. 31, 2026 352,455   352,836          
Ending balance at Jul. 31, 2026 $ 2,149,664   $ 35 $ (51,990) $ 12,501,139 $ (17,977) $ (10,281,543)  
Ending balance, treasury stock (in shares) at Jul. 31, 2026 (381)     (381)